Telehealth for Childhood Asthma
(TEACH-ER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method for caring for children with asthma after an emergency room visit. The study compares two approaches: one group receives enhanced standard care (Enhanced Care, EC), while the other receives additional support through telehealth visits and specialized education on managing asthma at home (Telehealth-Enhanced Asthma Care for Home After the Emergency Room, TEACH-ER). The researchers aim to determine if telehealth can reduce the need for further emergency visits, improve asthma symptoms, and enhance the quality of life for children. Children aged 3 to 12 who recently visited the emergency room for asthma and live in Monroe County, NY, may be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to innovative asthma care strategies that could improve children's health and well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It seems likely that participants will continue their current asthma medications, as the study focuses on enhancing asthma care.
What prior data suggests that this telehealth approach is safe for childhood asthma care?
Research has shown that telehealth for children with asthma is generally safe and effective. Studies have found that telemedicine helps children adhere to their treatment plans and improves their quality of life while reducing unexpected emergency room visits.
No serious side effects have been reported in studies on telehealth for asthma care. Regular online check-ins enable children to manage their asthma better. This method educates families about asthma and ensures correct medication use, with no major safety issues identified.
In summary, telehealth for asthma management appears to be a safe choice for children, aiding in asthma control without introducing new risks.12345Why are researchers excited about this trial?
Researchers are excited about Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) because it offers a new way to manage childhood asthma using telehealth technology right after an emergency room visit. Unlike traditional asthma care, which typically involves in-person follow-ups and standard medication management, TEACH-ER integrates virtual check-ins and personalized care plans, making it easier for families to manage asthma symptoms at home. This approach not only aims to reduce the need for repeat hospital visits but also empowers parents and children with real-time support and guidance from healthcare professionals. By leveraging technology, TEACH-ER could significantly improve asthma management and overall quality of life for children with asthma.
What evidence suggests that this trial's treatments could be effective for childhood asthma?
Research shows that telehealth can improve asthma management after an emergency room visit. In this trial, participants in the Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) arm will receive a new model of patient-centered asthma management. Studies on similar telehealth programs have found that children experienced better asthma control and missed fewer school days. For instance, children using telehealth had an average of 1.32 more symptom-free days and were less likely to need another emergency visit. This evidence suggests that telehealth can help maintain asthma control and reduce hospital visits. Meanwhile, participants in the Enhanced Care (EC) Comparison Group will receive standard emergency department care for asthma exacerbations, enhanced through a report of recent symptoms sent to PCPs and systematic feedback on asthma management.12467
Are You a Good Fit for This Trial?
This trial is for children aged 3-12 with persistent asthma or poor control, living in Monroe County, NY. They must have had an emergency visit for acute asthma and be on a daily controller medication as per NHLBI guidelines. Excluded are those who can't understand English or Spanish, lack phone access, are in foster care without guardian consent, or have other significant medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Education and Discharge
Brief, pictorial, and health literacy-informed asthma education in the ED, with color- and shape-coded labels provided for home asthma medications
Telehealth Follow-up
Virtual primary care follow-up within 1 week of discharge using in-home telemedicine, featuring provider prompts for guideline-based preventive therapy and home delivery of prescribed medications with pictorial action plans
Continued Virtual Visits
Two additional in-home virtual visits to reinforce teaching, review treatment plans, label medications, and support effective management practices
Follow-up
Participants are monitored for safety and effectiveness after treatment through blinded follow-up telephone surveys at 3, 6, 9, and 12 months after discharge
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Care (EC)
- Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator